What is a Community of Practice?

A community of practice is a group of people who work together and interact to learn from each other, sharing challenges, experiences and good practices in a particular area of their professional practice.

Since 2018, Q-CROC has established and coordinates several communities of practice in oncology clinical research.

Who Can Participate?

Physicians, research nurses, managers, and research coordinators. At the heart of the community of practice concept is the idea of learning by interacting with others.

BENEFITS OF COMMUNITIES OF PRACTICE

REFER PATIENTS

To establish an effective system for referring patients between centers

CIRCULATE INFORMATION

Quickly inform all centers of ongoing trials and upcoming ones

INCREASE VISIBILITY

To increase the community’s visibility among trial promoters

Thoracic (Résot)

Launched in 2018, RÉSOT was the first community of practice implemented by Q-CROC. Today, it has more than 80 members in 16 hospital centers across Quebec. Dr. Nathalie Daaboul (Hôpital Charles-Le Moyne) acts as a leader for RÉSOT.

Neuro-Oncology

Launched in the winter of 2022, this community brings together nearly 30 physicians from 11 centers across Quebec. Among other things, this community allows for the optimization of recruitment and the referral of patients between hospitals. The current leader of the community is Dr. Jean-Paul Bahary of CHUM.

Melanoma

Launched in 2023, the Melanoma Community of Practice relies on the involvement of about 30 professionals across Quebec. Dr Rahima Jamal (CHUM) is the leader for this community.

Gastrointestinal

In collaboration with Colorectal Cancer Canada, a community of practice was launched in the fall of 2020. Representatives from a dozen centers are already involved in this community. Dr Francine Aubin (CHUM) acts as a leader for this community.

Neurology, Radiology & GynecologY

A community of practice in neurology, radiology & gynecology was launched at the end of 2023. Under the leadership of Dr Jean-Paul Bahary (CHUM), this community aims to increase the number and facilitate the opening of new clinical trials.